Department of Gastrointestinal Surgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Gut. 2022 Feb;71(2):322-332. doi: 10.1136/gutjnl-2020-323703. Epub 2021 Feb 25.
The systemic spread of colorectal cancer (CRC) is dominated by the portal system and exhibits diverse patterns of metastasis without systematical genomic investigation. Here, we evaluated the genomic evolution of CRC with multiorgan metastases using multiregion sequencing.
Whole-exome sequencing was performed on multiple regions (n=74) of matched primary tumour, adjacent non-cancerous mucosa, liver metastasis and lung metastasis from six patients with CRC. Phylogenetic reconstruction and evolutionary analyses were used to investigate the metastatic seeding pattern and clonal origin. Recurrent driver gene mutations were analysed across patients and validated in two independent cohorts. Metastatic assays were performed to examine the effect of the novel driver gene on the malignant behaviour of CRC cells.
Based on the migration patterns and clonal origins, three models were revealed (sequential, branch-off and diaspora), which not only supported the anatomic assumption that CRC cells spread to lung after clonally expanding in the liver, but also illustrated the direct seeding of extrahepatic metastases from primary tumours independently. Unlike other cancer types, polyphyletic seeding occurs in CRC, which may result in late metastases with intermetastatic driver gene heterogeneity. In cases with rapid dissemination, we found recurrent trunk loss-of-function mutations in , which is enriched in metastatic CRC and associated with poor overall survival. CRISPR/Cas9-mediated knockout of enhances the metastatic potential of CRC cells.
Our results provide genomic evidence for metastatic evolution and indicate that biopsy/sequencing of metastases may be considered for patients with CRC with multiorgan or late postoperative metastasis.
结直肠癌(CRC)的全身扩散主要通过门脉系统进行,并表现出多种转移模式,而没有系统的基因组研究。在此,我们使用多区域测序评估了具有多器官转移的 CRC 的基因组进化。
对 6 名 CRC 患者的匹配原发肿瘤、相邻非癌粘膜、肝转移和肺转移的多个区域(n=74)进行了全外显子组测序。利用系统发育重建和进化分析来研究转移播种模式和克隆起源。在两个独立的队列中分析了跨患者的复发性驱动基因突变,并进行了验证。进行转移测定以检查新驱动基因对 CRC 细胞恶性行为的影响。
基于迁移模式和克隆起源,揭示了三种模型(顺序、分支和播散),不仅支持了 CRC 细胞在肝内克隆扩增后扩散到肺的解剖学假设,还说明了原发性肿瘤独立地直接播种肝外转移。与其他癌症类型不同,多系播种发生在 CRC 中,这可能导致转移性肿瘤具有不同的驱动基因异质性。在快速扩散的情况下,我们发现了 中频繁出现的主干功能丧失突变,该突变在转移性 CRC 中富集,并与整体生存不良相关。CRISPR/Cas9 介导的 基因敲除增强了 CRC 细胞的转移潜力。
我们的结果为转移进化提供了基因组证据,并表明对于具有多器官或术后晚期转移的 CRC 患者,可能需要考虑对转移灶进行活检/测序。